Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

DSG2 Gene Dilated Cardiomyopathy Type 1BB Genetic Test in UAE | 2,800 AED

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 & CAP-Accredited Next-Generation Sequencing (NGS).
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
Clinical Guidance: Dedicated post-test tele-consultation with a Consultant Medical Genetics specialist for comprehensive result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The DSG2 gene NGS test analyzes the entire coding region, splice sites, and deep intronic boundaries for mutations linked to dilated cardiomyopathy type 1BB. This comprehensive analysis enables definitive molecular diagnosis, accurate family risk stratification, and informed clinical management. The test is performed at DNA Labs UAE using an ISO 15189 accredited NGS platform with variant classification strictly adhering to ACMG guidelines.

Feature DNA Labs UAE NGS Test Conventional Sanger Sequencing
Technology Next‑Generation Sequencing (NGS) Limited Single‑Gene Sanger
Coverage All exons, splice sites, deep intronic regions Selected exons only
Turnaround Time 21 – 28 Days 42 – 56 Days
Diagnostic Yield >99.9% sensitivity; variant classification per ACMG ~70% sensitivity for known familial mutations

Physician Insight & Safety Protocols

"As a Consultant Medical Genetics specialist, I emphasize that the DSG2 NGS test provides highly accurate molecular data for assessing familial dilated cardiomyopathy risk. However, genetic results must be interpreted within the full context of clinical evaluation, family history, and electrocardiographic findings. A positive result indicates a predisposition, not a definitive diagnosis. Comprehensive pre- and post-test genetic counseling is paramount for informed medical decision-making."
– Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Medication & Clinical Advisory

Important Medication Advisory

Do not discontinue or modify any prescribed cardiac therapy or medication regimen based solely on genetic test results. All findings must be reviewed with your referring physician or cardiologist to ensure alignment with your current clinical status and treatment plan.

Exclusion Criteria & Urgent Clinical Indicators

Sample Collection Exclusions

  • Active systemic infection or acute febrile illness (defer collection until clinically stable).
  • Major surgery, significant trauma, or blood transfusion within the past 4 weeks.
  • Pregnancy or breastfeeding (testing is possible but requires specialized genetic counseling).

Emergency Warning Signs

Seek immediate emergency care if you or a family member experiences unexplained chest pain, palpitations, syncope (fainting), or acute shortness of breath.

Patient FAQ & Clinical Guidance

1. What is the accuracy of the DSG2 NGS test for diagnosing familial dilated cardiomyopathy?

Our ISO-accredited NGS platform achieves >99.9% analytical sensitivity and adheres strictly to ACMG variant interpretation standards, providing definitive molecular confirmation for clinical decision-making.

2. Can this genetic test be performed on a child or infant?

Yes, predictive genetic testing for minors is permissible under UAE regulatory frameworks governing genetic diagnostics. It requires explicit parental or guardian consent, a formal clinical genetics referral, and mandatory pre-test genetic counseling.

3. What is the process following a positive DSG2 mutation result?

You will receive a comprehensive tele-consultation with our Consultant Medical Genetics specialist, including personalized risk stratification, tailored family cascade screening recommendations, and a referral for ongoing cardiology surveillance and support.

UAE Regulatory & Data Privacy Adherence

Regulatory Compliance Framework

DNA Labs UAE strictly operates under the governance of the Dubai Healthcare City Authority of Regulation (DHCR) and adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical genetic testing procedures and patient consent protocols comply fully with Federal Decree-Law No. 4 of 2016 on Medical Liability. Your genetic data is encrypted, securely stored, and never shared without explicit informed consent.

Clinical & Logistical Metadata

Test Name DSG2 Gene Dilated Cardiomyopathy Type 1BB Genetic Test
Price (AED) 2,800 AED
Turnaround Time 21 – 28 Days
Sample Type / Matrix Whole Blood or Saliva
Methodology Used Next-Generation Sequencing (NGS)
ICD-10-CM Code I42.0 (Dilated Cardiomyopathy)
LOINC Code 92784-0 (DSG2 gene mutation analysis)
DHA Facility License & Address License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians